Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29109 | 157 | 26.6 | 38% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1220 | 8650 | TRIMETAZIDINE//DIABETIC CARDIOMYOPATHY//PERHEXILINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PERHEXILINE | Author keyword | 38 | 66% | 22% | 35 |
2 | HYDROXYPERHEXILINE | Author keyword | 3 | 100% | 2% | 3 |
3 | PERHEXILINE MALEATE | Author keyword | 2 | 43% | 2% | 3 |
4 | CARDIOL CLIN PHARMACOL | Address | 2 | 19% | 5% | 8 |
5 | CYPD2D6 | Author keyword | 1 | 50% | 1% | 1 |
6 | HUVEC HUMAN UMBILICAL VEIN ENDOTHELIAL CELL | Author keyword | 1 | 50% | 1% | 1 |
7 | VASC DIS THER EUT GRP | Address | 1 | 50% | 1% | 1 |
8 | METABOLIC RATIO | Author keyword | 0 | 10% | 3% | 4 |
9 | ANTI ANGINAL | Author keyword | 0 | 33% | 1% | 1 |
10 | DRUG WITHDRAWALS | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PERHEXILINE | 38 | 66% | 22% | 35 | Search PERHEXILINE | Search PERHEXILINE |
2 | HYDROXYPERHEXILINE | 3 | 100% | 2% | 3 | Search HYDROXYPERHEXILINE | Search HYDROXYPERHEXILINE |
3 | PERHEXILINE MALEATE | 2 | 43% | 2% | 3 | Search PERHEXILINE+MALEATE | Search PERHEXILINE+MALEATE |
4 | CYPD2D6 | 1 | 50% | 1% | 1 | Search CYPD2D6 | Search CYPD2D6 |
5 | HUVEC HUMAN UMBILICAL VEIN ENDOTHELIAL CELL | 1 | 50% | 1% | 1 | Search HUVEC+HUMAN+UMBILICAL+VEIN+ENDOTHELIAL+CELL | Search HUVEC+HUMAN+UMBILICAL+VEIN+ENDOTHELIAL+CELL |
6 | METABOLIC RATIO | 0 | 10% | 3% | 4 | Search METABOLIC+RATIO | Search METABOLIC+RATIO |
7 | ANTI ANGINAL | 0 | 33% | 1% | 1 | Search ANTI+ANGINAL | Search ANTI+ANGINAL |
8 | DRUG WITHDRAWALS | 0 | 33% | 1% | 1 | Search DRUG+WITHDRAWALS | Search DRUG+WITHDRAWALS |
9 | IN VIVO EXTRAPOLATION | 0 | 25% | 1% | 1 | Search IN+VIVO+EXTRAPOLATION | Search IN+VIVO+EXTRAPOLATION |
10 | PHARMACOGENETIC TESTS | 0 | 25% | 1% | 1 | Search PHARMACOGENETIC+TESTS | Search PHARMACOGENETIC+TESTS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTIANGINAL AGENT PERHEXILINE | 6 | 100% | 3% | 4 |
2 | IMPAIRED OXIDATION | 5 | 33% | 8% | 13 |
3 | PLASMA PERHEXILINE | 1 | 100% | 1% | 2 |
4 | POLYMORPHIC HYDROXYLATION | 1 | 12% | 4% | 6 |
5 | CORONARY ARTERY DISTRIBUTION | 1 | 50% | 1% | 1 |
6 | CARNITINE PALMITOYLTRANSFERASE 1 | 0 | 18% | 1% | 2 |
7 | OXFENICINE | 0 | 17% | 1% | 2 |
8 | QUALITY CONTROL SYSTEMS | 0 | 25% | 1% | 1 |
9 | TRICYCLIC ANTIDEPRESSANT AMINEPTINE | 0 | 17% | 1% | 1 |
10 | CARDIOVASCULAR PHARMACOLOGY | 0 | 14% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Perhexiline | 2007 | 40 | 50 | 50% |
Can pharmacogenetics help rescue drugs withdrawn from the market? | 2006 | 79 | 90 | 17% |
IS PERHEXILINE ESSENTIAL FOR THE OPTIMAL MANAGEMENT OF ANGINA-PECTORIS | 1995 | 11 | 7 | 71% |
Modulation of myocardial metabolism: an emerging therapeutic principle | 2010 | 15 | 28 | 18% |
ATENOLOL AND ISCHEMIC-HEART-DISEASE - AN OVERVIEW | 1991 | 5 | 26 | 12% |
BIOCHEMICAL BASIS TO BLOCK ISCHEMIA DEVELOPING INTO MYOCARDIAL-INFARCTION - A SHORT REVIEW | 1981 | 1 | 4 | 75% |
Genetic predisposition to drug-induced liver disease | 1995 | 8 | 128 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIOL CLIN PHARMACOL | 2 | 19% | 5.1% | 8 |
2 | VASC DIS THER EUT GRP | 1 | 50% | 0.6% | 1 |
3 | CARNEY PHARMACOGEN | 0 | 13% | 0.6% | 1 |
4 | N CHICAGO VA MED | 0 | 13% | 0.6% | 1 |
5 | CENT ADELAIDE LOCAL HLTH NETWORK | 0 | 10% | 0.6% | 1 |
6 | CLIN PHARMACOL CARDIOL | 0 | 10% | 0.6% | 1 |
7 | KINGS BHF | 0 | 10% | 0.6% | 1 |
8 | AUSTRALIAN PEDIAT PHARMACOKINET | 0 | 100% | 0.6% | 1 |
9 | HUMAN AEROSPACE PHYSIOL SCI | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000149811 | TRIMETAZIDINE//TRIMETAZIDINE MB//TRIMETASIDINE |
2 | 0.0000143814 | CYP2D6//DEBRISOQUINE//CYP2C19 |
3 | 0.0000090959 | HUMAN MUSCLE DEVELOPMENT//UNITE PEDAG RECH MED//HUMAN MUSCLE CULTURE |
4 | 0.0000084354 | PROGRAM INTEGRAT CARDIAC METAB//HERITAGE MED 423//CARDIAC METABOLISM |
5 | 0.0000082164 | MULTIFOCAL ATRIAL TACHYCARDIA//CHAOTIC ATRIAL RHYTHM//CHAOTIC ATRIAL TACHYCARDIA |
6 | 0.0000078587 | GLUCOSE INSULIN POTASSIUM//THORAC PHYSIOL//GIK |
7 | 0.0000075433 | MILDRONATE//MET 88//GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR |
8 | 0.0000065047 | PLASMA RECALCIFICATION//TAIL BLEEDING TIME//RAT PLATELET |
9 | 0.0000062521 | PHOSPHOLIPIDOSIS//DRUG INDUCED PHOSPHOLIPIDOSIS//CATIONIC AMPHIPHILIC DRUGS |
10 | 0.0000058915 | HYPOXIC HEART DAMAGE//EHF DIELECTROMETRY//NO FLOW PHENOMENON |